QPID Health, a Boston, MA-based developer of clinical intelligence solutions for healthcare providers, raised $12.3m in Series B funding.
The round, which followed a $4.4m Series A round (read here), was led by New York City-based New Leaf Venture Partners with participation from existing investors Cardinal Partners, Matrix Partners, Massachusetts General Physicians Organization, and Partners Innovation Fund. In conjunction with the funding, New Leaf’s Managing Director Philippe Chambon joined QPID Health’s board of directors.
The company intends to use the funds to expand adoption for its clinical intelligence solution among hospitals and healthcare systems in the U.S.
Led by CEO Mike Doyle, QPID Health provides a clinical intelligence solution that allows clinicians to get access to patient data stored in electronic health records (EHRs) and other backend data repositories. In 2013, its first year of commercial operation, the company ended the year with 4,000 active clinical users, grown to nearly 5,000 clinician users in Q1 2014.
Current customers include Massachusetts General and Brigham & Women’s Hospitals as well as other members of the Partners HealthCare system.